Tag: chemoBrain

Articles

• Chemo brain symptoms and outcomes

News

10/01/17

Exercise during first two years can improve symptoms of chemo brain

07/15/14

Significant improvements in chemo brain are typical within 3 years

08/25/13

Chemo brain can mean impaired decision making, attention and memory

Studies

• Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial Cite
  Brunet J, Sharma S, Zadravec K, Taljaard M, LeVasseur N, Srikanthan A, et al. Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial. Cancer. Wiley; 2024; 10.1002/cncr.35540
• Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study Cite
  Kerkmann A, Schinke C, Dordevic A, Kern J, Bangemann N, Finck J, et al. Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae268
• Computerized cognitive training improves cognitive function in primary breast cancer survivors Cite
  Kleinknecht KR, Bierend M, Keim L, Bartels F, Lampit A, Finke C. Computerized cognitive training improves cognitive function in primary breast cancer survivors. npj Breast Cancer. Springer Science and Business Media LLC; 2024; 10 10.1038/s41523-024-00694-8
• Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53–SIRT1 dependent pathway Cite
  Ebrahim NA, Elnagar MR, El-Gamal R, Habotta OA, Albadawi EA, Albadrani M, et al. Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53–SIRT1 dependent pathway. Heliyon. Elsevier BV; 2024; 10:e38081 10.1016/j.heliyon.2024.e38081
• 287P Cognitive impairment in older breast cancer survivors Cite
  Giordano S, Liao K, Pena J, Kim R, Zorzi D, Li L, et al. 287P Cognitive impairment in older breast cancer survivors. Annals of Oncology. Elsevier BV; 2024; 35:S335 10.1016/j.annonc.2024.08.228
• Low Sucrose Diets Protect Long-Term Memory and EPA & DHA Enriched Diets Alter Insulin Resistance in a Mouse Model of Chemotherapy Cite
  Ormiston K, Fitzgerald J, Andridge R, Lustberg MB, DeVries AC, Orchard TS. Low Sucrose Diets Protect Long-Term Memory and EPA & DHA Enriched Diets Alter Insulin Resistance in a Mouse Model of Chemotherapy. Nutrition Research. Elsevier BV; 2024; 10.1016/j.nutres.2024.09.004
• Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study Cite
  Mandelblatt J, Dage JL, Zhou X, Small BJ, Ahles TA, Ahn J, et al. Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 116:1495-1507 10.1093/jnci/djae113
• Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors Cite
  Hsiao C, Goto T, Von Ah D, Saligan LN. Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors. Seminars in Oncology Nursing. Elsevier BV; 2024;:151721 10.1016/j.soncn.2024.151721
• Physical Activity and Cognition: Longitudinal findings from the Thinking and Living with Cancer Study Cite
  Artese AL, Zhou X, Tometich DB, Small BJ, Ahles TA, Ahn J, et al. Physical Activity and Cognition: Longitudinal findings from the Thinking and Living with Cancer Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 10.1093/jnci/djae182
• Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach Cite
  Agelink van Rentergem JA, Lee Meeuw Kjoe PR, Vermeulen IE, Schagen SB. Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 18:810-817 10.1007/s11764-022-01310-z
• Measurement of Cognitive Function in Exercise Oncology Studies in Patients Treated With Chemotherapy: A Scoping Review Cite
  Moon C, Wilson RL, Gonzalo-Encabo P, Kang D, Mithani S, Dieli-Conwright CM, et al. Measurement of Cognitive Function in Exercise Oncology Studies in Patients Treated With Chemotherapy: A Scoping Review. Integrative Cancer Therapies. SAGE Publications; 2024; 23 10.1177/15347354241265349
• Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer Cite
  Cai C, Strickland K, Knudsen S, Tucker SB, Chidrala CS, Modugno F. Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer. JAMA Network Open. American Medical Association (AMA); 2024; 7:e2422493 10.1001/jamanetworkopen.2024.22493
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer Cite
  Otto-Dobos L, Grant C, Lahoud A, Wilcox O, Strehle L, Loman B, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. Elsevier BV; 2024; 120:208-220 10.1016/j.bbi.2024.05.039
• Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study Cite
  Duivon M, Lequesne J, Di Meglio A, Pradon C, Vaz-Luis I, Martin A, et al. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study. Breast Cancer Research. Springer Science and Business Media LLC; 2024; 26 10.1186/s13058-024-01850-5
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer Cite
  Otto-Dobos L, Grant C, Lahoud A, Wilcox O, Strehle L, Loman B, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. Elsevier BV; 2024; 10.1016/j.bbi.2024.05.039
• Cognitive impairment following breast cancer treatments: an umbrella review Cite
  Oliva G, Giustiniani A, Danesin L, Burgio F, Arcara G, Conte P. Cognitive impairment following breast cancer treatments: an umbrella review. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae090
• A Systematic Review Focused On Understanding the Effects of Modifiable Factors in Patients who Suffer from Chemotherapy Induced Cognitive Impairments or “Chemobrain” Cite
  Sharafkhaneh S, Meshkati N, Khan A, Shepherd H. A Systematic Review Focused On Understanding the Effects of Modifiable Factors in Patients who Suffer from Chemotherapy Induced Cognitive Impairments or “Chemobrain”. Research Square Platform LLC; 2024; 10.21203/rs.3.rs-4227713/v1
• Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved Cite
  Serini S, Calviello G. Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved. Antioxidants. MDPI AG; 2024; 13:486 10.3390/antiox13040486
• Enhanced antichemobrain activity of amino acid assisted ferulic acid solid dispersion in adult zebrafish (Danio rerio) Cite
  Shukla D, Kaur S, Singh A, Narang RK, Singh C. Enhanced antichemobrain activity of amino acid assisted ferulic acid solid dispersion in adult zebrafish (Danio rerio). Drug Delivery and Translational Research. Springer Science and Business Media LLC; 2024; 10.1007/s13346-024-01546-5
• Prediction of cognitive decline in older breast cancer survivors: the thinking and living with cancer study Cite
  Mcdeed AP, Van Dyk K, Zhou X, Zhai W, Ahles TA, Bethea TN, et al. Prediction of cognitive decline in older breast cancer survivors: the thinking and living with cancer study. JNCI Cancer Spectrum. Oxford University Press (OUP); 2024; 10.1093/jncics/pkae019
• Pervasive environmental chemicals impair oligodendrocyte development Cite
  Cohn EF, Clayton BLL, Madhavan M, Lee KA, Yacoub S, Fedorov Y, et al. Pervasive environmental chemicals impair oligodendrocyte development. Nature Neuroscience. Springer Science and Business Media LLC; 2024; 10.1038/s41593-024-01599-2
• Pervasive environmental chemicals impair oligodendrocyte development Cite
  Cohn EF, Clayton BLL, Madhavan M, Lee KA, Yacoub S, Fedorov Y, et al. Pervasive environmental chemicals impair oligodendrocyte development. Nature Neuroscience. Springer Science and Business Media LLC; 2024; 10.1038/s41593-024-01599-2
• A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times? Cite
  Merceur M, Reilly KT, Bonan I, Holé J, Hummel E, Cogné M, et al. A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?. Annals of Physical and Rehabilitation Medicine. Elsevier BV; 2024; 67:101832 10.1016/j.rehab.2024.101832
• Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021 Cite
  Amani O, Mazaheri MA, Moghani MM, Zarani F, Choolabi RH. Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021. Cancer Reports. Wiley; 2024; 7 10.1002/cnr2.1989
• Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: The Exercise Program in Cancer and Cognition randomized controlled trial Cite
  Bender CM, Sereika SM, Gentry AL, Cuglewski C, Duquette J, Grove G, et al. Effects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: The Exercise Program in Cancer and Cognition randomized controlled trial. Psycho-Oncology. Wiley; 2024; 33 10.1002/pon.6298
• Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study Cite
  Naaktgeboren WR, Koevoets EW, Stuiver MM, van Harten WH, Aaronson NK, van der Wall E, et al. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-023-07220-7
• Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy Cite
  Chen VC, Wu Y, Tsai Y, Weng J. Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy. Journal of Clinical Medicine. MDPI AG; 2024; 13:668 10.3390/jcm13030668
• Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer Cite
  Li W, Gan C, Yu S, Xu J, Tang L, Cheng H. Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer. Molecular Neurobiology. Springer Science and Business Media LLC; 2024; 10.1007/s12035-023-03910-x
• Diosmin alleviates Doxorubicin-induced chemobrain in rats via inhibition of oxido-inflammation, apoptosis and modulation of autophagy Cite
  Mega OO, Faith FY, Ejiro OP, Uchechukwu JG, Temitope OG, Oghenetega OB, et al. Diosmin alleviates Doxorubicin-induced chemobrain in rats via inhibition of oxido-inflammation, apoptosis and modulation of autophagy. Brain Disorders. Elsevier BV; 2023;:100111 10.1016/j.dscb.2023.100111
• Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol Cite
  Elia C, de Girolamo L, Clarisse B, Galin M, Rehel S, Clochon P, et al. Effects of sleep disturbances and circadian rhythms modifications on cognition in breast cancer women before and after adjuvant chemotherapy: the ICANSLEEP-1 protocol. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11664-x
• Early change in fatigue, insomnia, and cognitive impairment and symptom severity at 3-years post-treatment in breast cancer survivors Cite
  Lee RM, Rash JA, Seal M, McCarthy J, Garland SN. Early change in fatigue, insomnia, and cognitive impairment and symptom severity at 3-years post-treatment in breast cancer survivors. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3581028/v1
• Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study Cite
  Beyer J, Couch R, Ruddy KJ, Zeydan B, Tosakulwong N, Lesnick TG, et al. Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study. Medicine. Ovid Technologies (Wolters Kluwer Health); 2023; 102:e35524 10.1097/md.0000000000035524
• Effect of Physical Exercise on MRI‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial Cite
  Koevoets EW, Petr J, Monninkhof EM, Geerlings MI, Witlox L, van der Wall E, et al. Effect of Physical Exercise on MRI‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial. Journal of Magnetic Resonance Imaging. Wiley; 2023; 10.1002/jmri.28967
• The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer Cite
  Schiaffino MK, Schumacher JR, Nalawade V, Nguyen PTN, Yakuta M, Gilbert PE, et al. The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer. Journal of Geriatric Oncology. Elsevier BV; 2023; 14:101610 10.1016/j.jgo.2023.101610
• Açai Berry Ameliorates Cognitive Impairment by Inhibiting NLRP3/ASC/CASP axis in STZ-Induced Diabetic Neuropathy in Mice Cite
  Impellizzeri D, Siracusa R, D'Amico R, Fusco R, Cordaro M, Cuzzocrea S, et al. Açai Berry Ameliorates Cognitive Impairment by Inhibiting NLRP3/ASC/CASP axis in STZ-Induced Diabetic Neuropathy in Mice. Journal of Neurophysiology. American Physiological Society; 2023; 10.1152/jn.00239.2023
• Overnight olfactory enrichment using an odorant diffuser improves memory and modifies the uncinate fasciculus in older adults Cite
  Woo CC, Miranda B, Sathishkumar M, Dehkordi-Vakil F, Yassa MA, Leon M. Overnight olfactory enrichment using an odorant diffuser improves memory and modifies the uncinate fasciculus in older adults. Frontiers in Neuroscience. Frontiers Media SA; 2023; 17 10.3389/fnins.2023.1200448
• Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review Cite
  Jesús O, Luis C, Matilde M. Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review. Breast Cancer. Springer Science and Business Media LLC; 2023; 10.1007/s12282-023-01484-z
• Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study Cite
  Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, et al. Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. Cancer. Wiley; 2023; 129:2409-2421 10.1002/cncr.34784
• Menopausal hormone therapy and dementia: nationwide, nested case-control study Cite
  Pourhadi N, Mørch LS, Holm EA, Torp-Pedersen C, Meaidi A. Menopausal hormone therapy and dementia: nationwide, nested case-control study. BMJ. BMJ; 2023;:e072770 10.1136/bmj-2022-072770
• Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: Results of a pragmatic follow-up study Cite
  Naaktgeboren W, Koevoets E, Stuiver M, Harten Wv, Aaronson N, Wall EVd, et al. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: Results of a pragmatic follow-up study. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3029690/v1
• Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial Cite
  Yeung L, Alschuler DM, Wall M, Luttmann-Gibson H, Copeland T, Hale C, et al. Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial. The American Journal of Clinical Nutrition. Elsevier BV; 2023; 10.1016/j.ajcnut.2023.05.011
• Structural Brain Changes After a Mindfulness-Based Intervention in Breast Cancer Survivors with Cognitive Complaints Cite
  Melis M, Blommaert J, Radwan A, Smeets A, Van der Gucht K, Deprez S, et al. Structural Brain Changes After a Mindfulness-Based Intervention in Breast Cancer Survivors with Cognitive Complaints. Mindfulness. Springer Science and Business Media LLC; 2023; 10.1007/s12671-023-02140-5
• Risk of All-Cause Dementia, Alzheimer Disease, and Vascular Dementia in Breast Cancer Survivors Cite
  Wennberg A, Ding M, Feychting M, Modig K. Risk of All-Cause Dementia, Alzheimer Disease, and Vascular Dementia in Breast Cancer Survivors. Neurology: Clinical Practice. Ovid Technologies (Wolters Kluwer Health); 2023; 13:e200173 10.1212/cpj.0000000000200173
• Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis Cite
  Hiensch AE, Beckhaus J, Witlox L, Monninkhof EM, Schagen SB, van Vulpen JK, et al. Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 10.1007/s11764-023-01392-3
• Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice Cite
  Lee TH, Devaki M, Formolo DA, Rosa JM, Cheng ASK, Yau S. Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice. International Journal of Environmental Research and Public Health. MDPI AG; 2023; 20:5371 10.3390/ijerph20075371
• Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus Cite
  Lal R, Dharavath RN, Chopra K. Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus. Neurochemical Research. Springer Science and Business Media LLC; 2023; 10.1007/s11064-023-03914-y
• Differences in total cognition and cerebrovascular function in female breast cancer survivors and cancer-free women Cite
  Downs TL, Whiteside EJ, Foot G, Mills DE, Bliss ES. Differences in total cognition and cerebrovascular function in female breast cancer survivors and cancer-free women. The Breast. Elsevier BV; 2023; 69:358-365 10.1016/j.breast.2023.03.018
• Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors Cite
  Ahles TA, Schofield E, Li Y, Ryan E, Orlow I, Patel SK, et al. Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 10.1007/s11764-023-01365-6
• Association between Endocrine Therapy and Cognitive Decline in Older Women with Early Breast Cancer: Findings from the Prospective CLIMB Study Cite
  Baltussen JC, Derks MG, Lemij AA, de Glas NA, Fiocco M, Linthorst-Niers EM, et al. Association between Endocrine Therapy and Cognitive Decline in Older Women with Early Breast Cancer: Findings from the Prospective CLIMB Study. European Journal of Cancer. Elsevier BV; 2023; 10.1016/j.ejca.2023.02.008
• Cognitive function and breast cancer molecular subtype before and after chemotherapy Cite
  Hsu Y, Chen H, Wu S, Tzang B, Hsieh C, Weng Y, et al. Cognitive function and breast cancer molecular subtype before and after chemotherapy. Applied Neuropsychology: Adult. Informa UK Limited; 2023;:1-8 10.1080/23279095.2023.2176233
• Cognitive change in breast cancer patients up to 2 years after diagnosis Cite
  Lange M, Arbogast SL, Hardy-Léger I, Rigal O, Le Fel J, Pistilli B, et al. Cognitive change in breast cancer patients up to 2 years after diagnosis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2022; 10.1093/jnci/djac240
• Association of Dietary Intake of Flavonols With Changes in Global Cognition and Several Cognitive Abilities Cite
  Holland TM, Agarwal P, Wang Y, Dhana K, Leurgans SE, Shea K, et al. Association of Dietary Intake of Flavonols With Changes in Global Cognition and Several Cognitive Abilities. Neurology. Ovid Technologies (Wolters Kluwer Health); 2022;:10.1212/WNL.0000000000201541 10.1212/wnl.0000000000201541
• Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls Cite
  Bilenduke E, Sterrett JD, Ranby KW, Borges VF, Grigsby J, Carr AL, et al. Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls. Scientific Reports. Springer Science and Business Media LLC; 2022; 12 10.1038/s41598-022-23793-7
• An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study Cite
  Tometich DB, Mosher CE, Cyders M, McDonald BC, Saykin AJ, Small BJ, et al. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Annals of Behavioral Medicine. Oxford University Press (OUP); 2022; 10.1093/abm/kaac048
• Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study Cite
  Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, et al. Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 10.1200/jco.22.00406
• Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration Cite
  Kara F, Lohse CM, Castillo AM, Tosakulwong N, Lesnick TG, Jack CR, et al. Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration. Cancer Medicine. Wiley; 2022; 10.1002/cam4.5175
• Neural correlates in functional brain mapping among breast cancer survivors receiving different chemotherapy regimens: a qEEG/HEG-based investigation Cite
  Vasaghi Gharamaleki M, Mousavi SZ, Owrangi M, Gholamzadeh MJ, Kamali A, Dehghani M, et al. Neural correlates in functional brain mapping among breast cancer survivors receiving different chemotherapy regimens: a qEEG/HEG-based investigation. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2022; 10.1093/jjco/hyac121
• Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health Cite
  Liesto S, Sipilä R, Hietanen M, Kalso E. Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health. The Breast. Elsevier BV; 2022; 10.1016/j.breast.2022.07.013
• Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors Cite
  Von Ah D, Crouch AD, Monahan PO, Stump TE, Unverzagt FW, Storey S, et al. Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2021; 16:812-822 10.1007/s11764-021-01075-x
• Dairy Product Consumption and Changes in Cognitive Performance: Two‐Year Analysis of the PREDIMED‐Plus Cohort Cite
  Ni J, Nishi SK, Babio N, Martínez‐González MA, Corella D, Castañer O, et al. Dairy Product Consumption and Changes in Cognitive Performance: Two‐Year Analysis of the PREDIMED‐Plus Cohort. Molecular Nutrition & Food Research. Wiley; 2022; 66:2101058 10.1002/mnfr.202101058
• The Effects of Chemotherapy on Circulating Plasma Omega-9, Omega-3 Fatty Acids and Plasmalogen in Breast Cancer Patients Cite
  Bennouna D, Orchard T, Lustberg M, Kopec R. The Effects of Chemotherapy on Circulating Plasma Omega-9, Omega-3 Fatty Acids and Plasmalogen in Breast Cancer Patients. Current Developments in Nutrition. Oxford University Press (OUP); 2022; 6:237-237 10.1093/cdn/nzac052.004
• Long-term changes of cognitive impairment among older breast cancer survivors Cite
  Luo J, Schousboe JT, Ensrud KE, Hendryx M. Long-term changes of cognitive impairment among older breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2022; 10.1007/s11764-022-01220-0
• Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage Cite
  Song C, Gao C, Wang Z. Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage. Brain Sciences. MDPI AG; 2022; 12:571 10.3390/brainsci12050571
• Abstract P4-11-09: Cancer-related cognitive impairment (CRCI) in early breast cancer (BC) survivors Cite
  Presti D, Joly F, Soldato D, Christodoulidis S, Noce AD, Havas J, et al. Abstract P4-11-09: Cancer-related cognitive impairment (CRCI) in early breast cancer (BC) survivors. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P4-11-09-P4-11-09 10.1158/1538-7445.sabcs21-p4-11-09
• Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study Cite
  Van Dyk K, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, et al. Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. JNCI Cancer Spectrum. Oxford University Press (OUP); 2021; 5 10.1093/jncics/pkab013
• Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy Cite
  Belcher EK, Culakova E, Gilmore NJ, Hardy SJ, Kleckner AS, Kleckner IR, et al. Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2022; 10.1093/jnci/djac022
• Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology Cite
  Karanth SD, Katsumata Y, Nelson PT, Fardo DW, McDowell JK, Schmitt FA, et al. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology. Brain. Oxford University Press (OUP); 2022; 10.1093/brain/awac035
• Pre-Treatment Breast Cancer Patients Show Neural Differences in Frontal Alpha Asymmetry Cite
  Prashad N, Melara RD, Root JC, Ahles TA. Pre-Treatment Breast Cancer Patients Show Neural Differences in Frontal Alpha Asymmetry. Clinical EEG and Neuroscience. SAGE Publications; 2022;:155005942210748 10.1177/15500594221074860
• Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial Cite
  Juan Z, Chen J, Ding B, Yongping L, Liu K, Wang L, et al. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. European Journal of Cancer. Elsevier BV; 2022; 161:10-22 10.1016/j.ejca.2021.11.006
• Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis Cite
  Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, et al. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06455-6
• Effects of plant-based versus marine-based omega-3 fatty acids and sucrose on brain and liver fatty acids in a mouse model of chemotherapy Cite
  Ormiston K, Gaudier-Diaz MM, TinKai T, Fitzgerald J, Cole RM, Andridge R, et al. Effects of plant-based versus marine-based omega-3 fatty acids and sucrose on brain and liver fatty acids in a mouse model of chemotherapy. Nutritional Neuroscience. Informa UK Limited; 2021;:1-9 10.1080/1028415x.2021.1998296
• Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors Cite
  Marín-Chollom AM, Hale C, Koch P, Gaffney AO, Contento I, Shen H, et al. Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors. Journal of Immigrant and Minority Health. Springer Science and Business Media LLC; 2021; 10.1007/s10903-021-01300-w
• Estrogenic hormones receptors in Alzheimer’s disease Cite
  Tecalco-Cruz AC, Zepeda–Cervantes J, Ortega-Domínguez B. Estrogenic hormones receptors in Alzheimer’s disease. Molecular Biology Reports. Springer Science and Business Media LLC; 2021; 10.1007/s11033-021-06792-1
• The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study Cite
  Ali AE, Elsherbiny DM, Azab SS, El-Demerdash E. The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study. NeuroToxicology. Elsevier BV; 2021; 10.1016/j.neuro.2021.10.002
• Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study Cite
  Zhang H, Li P, Liu T, Wang X, Feng W, Chen R, et al. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2021; 10.1007/s11682-021-00551-3
• 125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy Cite
  Lobbedez FJ, Hardy-Léger I, Arbogast SL, Rigal O, Le Fel J, Pistilli B, et al. 125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy. Annals of Oncology. Elsevier BV; 2021; 32:S412-S413 10.1016/j.annonc.2021.08.406
• Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview Cite
  Zabłocka A, Kazana W, Sochocka M, Stańczykiewicz B, Janusz M, Leszek J, et al. Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview. Molecular Neurobiology. Springer Science and Business Media LLC; 2021; 10.1007/s12035-021-02544-1
• Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment Cite
  Moretti R, Dias E, Kiel S, Augusto M, Rodrigues P, Sampaio A, et al. Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. Research in Veterinary Science. Elsevier BV; 2021; 10.1016/j.rvsc.2021.09.009
• Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time Cite
  Van Dyk K, Crespi CM, Bower JE, Carroll JE, Petersen L, Ganz PA. Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00327-4
• Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review Cite
  Jebahi F, Sharma S, Bloss JE, Wright HH. Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review. Psycho-Oncology. Wiley; 2021; 30:1262-1277 10.1002/pon.5696
• Breast Arterial Calcification Is Not Associated with Mild Cognitive Impairment or Incident All-Cause Dementia Among Postmenopausal Women: The MINERVA Study Cite
  Iribarren C, Chandra M, Molloi S, Sanchez G, Azamian-Bidgoli F, Cho H, et al. Breast Arterial Calcification Is Not Associated with Mild Cognitive Impairment or Incident All-Cause Dementia Among Postmenopausal Women: The MINERVA Study. Journal of Women's Health. Mary Ann Liebert Inc; 2021; 30:848-856 10.1089/jwh.2020.8372
• Chemo-Brain: An Activation Likelihood Estimation Meta-Analysis of Functional Magnetic Resonance Imaging Studies Cite
  Bernstein LJ, Edelstein K, Sharma A, Alain C. Chemo-Brain: An Activation Likelihood Estimation Meta-Analysis of Functional Magnetic Resonance Imaging Studies. Neuroscience & Biobehavioral Reviews. Elsevier BV; 2021; 10.1016/j.neubiorev.2021.08.024
• Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship Cite
  Chung N, Chang A, Gillis R, Sloan E, Walker AK. Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-783452/v1
• Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study Cite
  Salerno EA, Culakova E, Kleckner AS, Heckler CE, Lin P, Matthews CE, et al. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.20.03514 10.1200/jco.20.03514
• Endocrine therapy with or without CDK4/6 inhibitors in women with hormone-receptor positive breast cancer: What do we know about the effects on cognition? Cite
  Kjoe PRLM, van der Wall E, Schagen SB. Endocrine therapy with or without CDK4/6 inhibitors in women with hormone-receptor positive breast cancer: What do we know about the effects on cognition?. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.08.002
• Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways Cite
  Oppegaard K, Harris CS, Shin J, Paul SM, Cooper BA, Chan A, et al. Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways. Cytokine. Elsevier BV; 2021; 148:155653 10.1016/j.cyto.2021.155653
• Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women Cite
  Yeh T, Yuan C, Ascherio A, Rosner B, Willett W, Blacker D. Long-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and Women. Neurology. Ovid Technologies (Wolters Kluwer Health); 2021;:10.1212/WNL.0000000000012454 10.1212/wnl.0000000000012454
• Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin Cite
  El-Asfar RK, El-Derany MO, Sallam AM, Wahdan SA, El-Demerdash E, Sayed SA, et al. Luteolin mitigates tamoxifen-associated fatty liver and cognitive impairment in rats by modulating beta-catenin. European Journal of Pharmacology. Elsevier BV; 2021; 908:174337 10.1016/j.ejphar.2021.174337
• Cognitive dysfunction prevalence and associated factors in older breast cancer survivors Cite
  Crouch A, Champion VL, Unverzagt FW, Pressler SJ, Huber L, Moser LR, et al. Cognitive dysfunction prevalence and associated factors in older breast cancer survivors. Journal of Geriatric Oncology. Elsevier BV; 2021; 10.1016/j.jgo.2021.07.001
• Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial Cite
  Hagiwara Y, Sawaki M, Uemura Y, Kawahara T, Shimozuma K, Ohashi Y, et al. Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06253-0
• Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC) Cite
  Araújo N, Severo M, Lopes-Conceição L, Fontes F, Dias T, Branco M, et al. Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC). The Breast. Elsevier BV; 2021; 10.1016/j.breast.2021.05.006
• Association of Endocrine Therapy and Dementia in Women with Breast Cancer Cite
  Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, et al. Association of Endocrine Therapy and Dementia in Women with Breast Cancer. Breast Cancer: Targets and Therapy. Informa UK Limited; 2021; Volume 13:219-224 10.2147/bctt.s300455
• Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide Cite
  Brown T, McElroy T, Simmons P, Walters H, Ntagwabira F, Wang J, et al. Cognitive Impairment Resulting from Treatment with Docetaxel, Doxorubicin, and Cyclophosphamide. Brain Research. Elsevier BV; 2021;:147397 10.1016/j.brainres.2021.147397
• Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study Cite
  De Rosa N, Della Corte L, Giannattasio A, Giampaolino P, Di Carlo C, Bifulco G. Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study. Archives of Gynecology and Obstetrics. Springer Science and Business Media LLC; 2021; 10.1007/s00404-020-05896-6
• Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE Cite
  Fernandez HR, Varma A, Flowers SA, Rebeck GW. Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE. Cancers. MDPI AG; 2020; 12:3842 10.3390/cancers12123842
• Cognitive Reserve, Incident Cancer, and Rate of Memory Decline in Later Life Cite
  Romero MO, Brenowitz W, Hayes-Larson E, Ackley SF, Mayeda ER, Glymour MM, et al. Cognitive Reserve, Incident Cancer, and Rate of Memory Decline in Later Life. Innovation in Aging. Oxford University Press (OUP); 2020; 4:146-146 10.1093/geroni/igaa057.477
• Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer Cite
  Bender CM, Sereika SM, Gentry AL, Duquette JE, Casillo FE, Marsland A, et al. Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 10.1007/s00520-020-05865-4
• Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion Cite
  Koppelmans V, van der Willik KD, Aleman BMP, van Leeuwen FE, Kavousi M, Arshi B, et al. Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05990-y
• Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study Cite
  Feng Y, Wang YF, Zheng LJ, Shi Z, Huang W, Zhang LJ. Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study. Cancer Imaging. Springer Science and Business Media LLC; 2020; 20 10.1186/s40644-020-00355-6
• Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms Cite
  Hsu Y, Chen VC, Hsieh C, Weng Y, Hsu Y, Hsiao H, et al. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms. Breast Cancer. Springer Science and Business Media LLC; 2020; 10.1007/s12282-020-01168-y
• Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation Cite
  Ali MA, Menze ET, Tadros MG, Tolba MF. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation. Neuropharmacology. Elsevier BV; 2020; 181:108334 10.1016/j.neuropharm.2020.108334
• Language impairment among patients with different types of cancer. Comparison with healthy adults Cite
  Megari K. Language impairment among patients with different types of cancer. Comparison with healthy adults. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 184:779-782 10.1007/s10549-020-05898-7
• Neuropsychiatric effects of tamoxifen: Challenges and opportunities Cite
  Novick AM, Scott AT, Neill Epperson C, Schneck CD. Neuropsychiatric effects of tamoxifen: Challenges and opportunities. Frontiers in Neuroendocrinology. Elsevier BV; 2020; 59:100869 10.1016/j.yfrne.2020.100869
• Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors Cite
  Fogel J, Rubin LH, Kilic E, Walega DR, Maki PM. Physiologic vasomotor symptoms are associated with verbal memory dysfunction in breast cancer survivors. Menopause. Ovid Technologies (Wolters Kluwer Health); 2020; 27:1209-1219 10.1097/gme.0000000000001608
• Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup Cite
  Lange M, Hardy-Léger I, Licaj I, Pistilli B, Rigal O, Le Fel J, et al. Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:1759-1766 10.1158/1055-9965.epi-20-0346
• The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada Cite
  Blanchette PS, Lam M, Le B, Richard L, Shariff SZ, Pritchard KI, et al. The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. Journal of Geriatric Oncology. Elsevier BV; 2020; 11:1132-1137 10.1016/j.jgo.2020.05.009
• The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer Cite
  Alatawi Y, Hansen RA, Chou C, Qian J, Suppiramaniam V, Cao G. The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer. European Geriatric Medicine. Springer Science and Business Media LLC; 2020; 11:1017-1026 10.1007/s41999-020-00349-4
• Special bioactive compounds and functional foods may exhibit neuroprotective effects in patients with dementia (Review) Cite
  Murakami M, Ikeda Y, Nakagawa Y, Tsuji A, Kitagishi Y, Matsuda S. Special bioactive compounds and functional foods may exhibit neuroprotective effects in patients with dementia (Review). Biomedical Reports. Spandidos Publications; 2020; 10.3892/br.2020.1310
• Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada. Cite
  Blanchette PS, Lam M, Le B, Richard L, Shariff S, Pritchard KI, et al. Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:521-521 10.1200/jco.2020.38.15_suppl.521
• Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy-naïve patients with early breast cancer. Cite
  Nakamura Z, Deal AM, Nyrop KA, Damone E, Muss HB. Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy-naïve patients with early breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:12114-12114 10.1200/jco.2020.38.15_suppl.12114
• Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis? Cite
  Small BJ, Jim HSL. Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis?. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2019; 112:431-432 10.1093/jnci/djz179
• Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial Cite
  Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, et al. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLOS ONE. Public Library of Science (PLoS); 2020; 15:e0231379 10.1371/journal.pone.0231379
• Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis Cite
  Tong T, Lu H, Zong J, Lv Q, Chu X. Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis. Breast Cancer. Springer Science and Business Media LLC; 2020; 27:893-902 10.1007/s12282-020-01094-z
• Oleic Acid Reduces Brain Injury by Oxidative Stress Induced by Some Anticancer Drugs in Rat Brain Cite
  Guzmán DC, Brizuela NO, Herrera MO, Olguin HJ, Jimenez FT, Peraza AV, et al. Oleic Acid Reduces Brain Injury by Oxidative Stress Induced by Some Anticancer Drugs in Rat Brain. Research Square; 2020; 10.21203/rs.3.rs-15472/v1
• Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy Cite
  Yamamoto S, Masutani E, Arao H. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy. Breast Cancer. Springer Science and Business Media LLC; 2020; 27:670-682 10.1007/s12282-020-01062-7
• Cognitive problems of breast cancer survivors on proton pump inhibitors Cite
  Madison AA, Woody A, Bailey B, Lustberg MB, Ramaswamy B, Wesolowski R, et al. Cognitive problems of breast cancer survivors on proton pump inhibitors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2020; 14:226-234 10.1007/s11764-019-00815-4
• Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors Cite
  Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Annals of Oncology. Elsevier BV; 2019; 30:1925-1940 10.1093/annonc/mdz410
• Causes of death after breast cancer diagnosis: A US population‐based analysis Cite
  Afifi AM, Saad AM, Al‐Husseini MJ, Elmehrath AO, Northfelt DW, Sonbol MB. Causes of death after breast cancer diagnosis: A US population‐based analysis. Cancer. Wiley; 2019; 126:1559-1567 10.1002/cncr.32648
• Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy Cite
  Yi L, Dong S, Wang S, Chen M, Li C, Geng D, et al. Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy. Neurobiology of Disease. Elsevier BV; 2019; 136:104715 10.1016/j.nbd.2019.104715
• Serum elaidic acid concentration and risk of dementia Cite
  Honda T, Ohara T, Shinohara M, Hata J, Toh R, Yoshida D, et al. Serum elaidic acid concentration and risk of dementia. Neurology. Ovid Technologies (Wolters Kluwer Health); 2019; 93:e2053-e2064 10.1212/wnl.0000000000008464
• Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions Cite
  Ongnok B, Chattipakorn N, Chattipakorn SC. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Experimental Neurology. Elsevier BV; 2020; 324:113118 10.1016/j.expneurol.2019.113118
• Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials Cite
  Xu Z, Luo F, Wang Y, Zou B, Man Y, Liu J, et al. Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials. Cancer Chemotherapy and Pharmacology. Springer Science and Business Media LLC; 2019; 85:61-67 10.1007/s00280-019-03994-0
• Cancer-related Cognitive Impairment Cite
  Vardy JL. Cancer-related Cognitive Impairment. Annals of Oncology. Elsevier BV; 2019; 30:vi43 10.1093/annonc/mdz349
• The relationship between diet and cognitive function in adult cancer survivors: a systematic review Cite
  Coro D, Hutchinson A, Dahlenburg S, Banks S, Coates A. The relationship between diet and cognitive function in adult cancer survivors: a systematic review. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2019; 13:773-791 10.1007/s11764-019-00796-4
• Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK Cite
  Bromley SE, Matthews A, Smeeth L, Stanway S, Bhaskaran K. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2019; 13:632-640 10.1007/s11764-019-00782-w
• The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors Cite
  Liou KT, Ahles TA, Garland SN, Li QS, Bao T, Li Y, et al. The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors. JNCI Cancer Spectrum. Oxford University Press (OUP); 2019; 3 10.1093/jncics/pkz041
• Acute aerobic exercise effects on cognitive function in breast cancer survivors: a randomized crossover trial Cite
  Salerno EA, Rowland K, Kramer AF, McAuley E. Acute aerobic exercise effects on cognitive function in breast cancer survivors: a randomized crossover trial. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5589-1
• Propofol alleviates cisplatin-related cognitive impairment Cite
  Zhou Y, Qiu Y. Propofol alleviates cisplatin-related cognitive impairment. Neurological Sciences. Springer Science and Business Media LLC; 2019; 40:1645-1649 10.1007/s10072-019-03895-3
• The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients Cite
  Gregorowitsch ML, Ghedri A, Young-Afat DA, Bijlsma R, Baas IO, van Schaik-van de Mheen C, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 175:429-441 10.1007/s10549-019-05149-4
• Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial) Cite
  Takahashi M, Sawaki M, Hagiwara Y, Uemura Y, Kawahara T, Shimozuma K, et al. Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial). Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p1-11-21
• Pharmacologic management of cognitive impairment induced by cancer therapy Cite
  Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. The Lancet Oncology. Elsevier BV; 2019; 20:e92-e102 10.1016/s1470-2045(18)30938-0
• Low dose aspirin blocks breast cancer-induced cognitive impairment in mice Cite
  Walker AK, Chang A, Ziegler AI, Dhillon HM, Vardy JL, Sloan EK. Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0208593 10.1371/journal.pone.0208593
• The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment Cite
  Van Dyk K, Crespi CM, Bower JE, Castellon SA, Petersen L, Ganz PA. The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment. Cancer. Wiley; 2018; 125:681-689 10.1002/cncr.31858
• Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level Cite
  Perrier J, Viard A, Levy C, Morel N, Allouache D, Noal S, et al. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2018; 14:226-241 10.1007/s11682-018-9991-0
• Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial Cite
  Gokal K, Munir F, Ahmed S, Kancherla K, Wallis D. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0206874 10.1371/journal.pone.0206874
• Cognitive performance in survivors of breast cancer and markers of biological aging Cite
  Carroll JE, Van Dyk K, Bower JE, Scuric Z, Petersen L, Schiestl R, et al. Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer. Wiley; 2018; 125:298-306 10.1002/cncr.31777
• Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study Cite
  Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, et al. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:3211-3222 10.1200/jco.18.00140
• Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration Cite
  McLeary F, Davis A, Rudrawar S, Perkins A, Anoopkumar-Dukie S. Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration. European Journal of Pharmacology. Elsevier BV; 2019; 842:49-56 10.1016/j.ejphar.2018.09.034
• Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients Cite
  Li X, Chen H, Lv Y, Chao HH, Gong L, Li CR, et al. Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Scientific Reports. Springer Science and Business Media LLC; 2018; 8 10.1038/s41598-018-32257-w
• Dimensions of sedentary behavior and objective cognitive functioning in breast cancer survivors Cite
  Marinac CR, Nelson SH, Cadmus-Bertram L, Kerr J, Natarajan L, Godbole S, et al. Dimensions of sedentary behavior and objective cognitive functioning in breast cancer survivors. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 27:1435-1441 10.1007/s00520-018-4459-8
• Low Serum Carotenoids Are Associated with Self-Reported Cognitive Dysfunction and Inflammatory Markers in Breast Cancer Survivors Cite
  Zuniga K, Moran N. Low Serum Carotenoids Are Associated with Self-Reported Cognitive Dysfunction and Inflammatory Markers in Breast Cancer Survivors. Nutrients. MDPI AG; 2018; 10:1111 10.3390/nu10081111
• Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy Cite
  Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, et al. Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. International Journal of Clinical Oncology. Springer Science and Business Media LLC; 2018; 24:68-77 10.1007/s10147-018-1330-3
• Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer Cite
  Lange M, Heutte N, Noal S, Rigal O, Kurtz J, Lévy C, et al. Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer. The Oncologist. Wiley; 2018; 24:62-68 10.1634/theoncologist.2017-0570
• Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer Cite
  Underwood EA, Pritchard KI, Jerzak K, Lebovic G, Elser C, Rochon P, et al. Abstract 601: Cognitive sequelae of adjuvant endocrine therapy in older women treated for early-stage breast cancer. Clinical Research (Excluding Clinical Trials). American Association for Cancer Research; 2018; 10.1158/1538-7445.am2018-601
• Replacing sedentary time with physical activity or sleep: effects on cancer-related cognitive impairment in breast cancer survivors Cite
  Ehlers DK, Fanning J, Salerno EA, Aguiñaga S, Cosman J, Severson J, et al. Replacing sedentary time with physical activity or sleep: effects on cancer-related cognitive impairment in breast cancer survivors. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4603-3
• Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study Cite
  Chen BT, Sethi SK, Jin T, Patel SK, Ye N, Sun C, et al. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study. Breast Cancer Research. Springer Science and Business Media LLC; 2018; 20 10.1186/s13058-018-0965-3
• Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors Cite
  Ng T, Dorajoo SR, Cheung YT, Lam YC, Yeo HL, Shwe M, et al. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors. Psycho-Oncology. Wiley; 2018; 27:1185-1192 10.1002/pon.4635
• Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain Cite
  Park H, Kim C, Kwak H, No M, Heo J, Kim T. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain. Neuropharmacology. Elsevier BV; 2018; 133:451-461 10.1016/j.neuropharm.2018.02.013
• Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis Cite
  Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 168:299-310 10.1007/s10549-017-4627-4
• Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer Cite
  Winocur G, Berman H, Nguyen M, Binns MA, Henkelman M, van Eede M, et al. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer. Neuroscience. Elsevier BV; 2018; 369:51-65 10.1016/j.neuroscience.2017.10.048
• Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up Cite
  Schmidt ME, Wiskemann J, Schneeweiss A, Potthoff K, Ulrich CM, Steindorf K. Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. International Journal of Cancer. Wiley; 2017; 142:1148-1157 10.1002/ijc.31138
• Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis Cite
  Bernstein LJ, McCreath GA, Komeylian Z, Rich JB. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis. Neuroscience & Biobehavioral Reviews. Elsevier BV; 2017; 83:417-428 10.1016/j.neubiorev.2017.10.028
• Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy Cite
  Williams AM, Shah R, Shayne M, Huston AJ, Krebs M, Murray N, et al. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. Journal of Neuroimmunology. Elsevier BV; 2018; 314:17-23 10.1016/j.jneuroim.2017.10.005
• Aspirin blocks cancer-associated cognitive impairment Cite
  Walker A, Sloan E. Aspirin blocks cancer-associated cognitive impairment. Brain, Behavior, and Immunity. Elsevier BV; 2017; 66:e21-e22 10.1016/j.bbi.2017.07.084
• Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study Cite
  Hartman SJ, Nelson SH, Myers E, Natarajan L, Sears DD, Palmer BW, et al. Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer. Wiley; 2017; 124:192-202 10.1002/cncr.30987
• Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review Cite
  Yao C, Bernstein LJ, Rich JB. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:15-28 10.1007/s10549-017-4376-4
• Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project Cite
  Hurtz H, Tesch H, Göhler T, Hutzschenreuter U, Harde J, Kruggel L, et al. Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:721-731 10.1007/s10549-017-4365-7
• The effects of physical activity and fatigue on cognitive performance in breast cancer survivors Cite
  Ehlers DK, Aguiñaga S, Cosman J, Severson J, Kramer AF, McAuley E. The effects of physical activity and fatigue on cognitive performance in breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:699-707 10.1007/s10549-017-4363-9
• Risk of Alzheimer's disease or dementia following a cancer diagnosis Cite
  Bowles EJA, Walker RL, Anderson ML, Dublin S, Crane PK, Larson EB. Risk of Alzheimer's disease or dementia following a cancer diagnosis. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0179857 10.1371/journal.pone.0179857
• Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging Cite
  Mo C, Lin H, Fu F, Lin L, Zhang J, Huang M, et al. Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging. Oncotarget. Impact Journals, LLC; 2017; 8:81273-81284 10.18632/oncotarget.18111
• Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls. Cite
  Janelsins MC, Heckler CE, Peppone LJ, Mohile SG, Mustian KM, Ahles T, et al. Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:10014-10014 10.1200/jco.2017.35.15_suppl.10014
• The ratio of 1/3 linoleic acid to alpha linolenic acid is optimal for oligodendrogenesis of embryonic neural stem cells Cite
  Hejr H, Ghareghani M, Zibara K, Ghafari M, Sadri F, Salehpour Z, et al. The ratio of 1/3 linoleic acid to alpha linolenic acid is optimal for oligodendrogenesis of embryonic neural stem cells. Neuroscience Letters. Elsevier BV; 2017; 651:216-225 10.1016/j.neulet.2017.05.020
• Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients Cite
  Hermelink K, Bühner M, Sckopke P, Neufeld F, Kaste J, Voigt V, et al. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 109 10.1093/jnci/djx057
• Cognitive functioning and emotion processing in breast cancer survivors and controls: An ERP pilot study Cite
  Wirkner J, Weymar M, Löw A, Hamm C, Struck A, Kirschbaum C, et al. Cognitive functioning and emotion processing in breast cancer survivors and controls: An ERP pilot study. Psychophysiology. Wiley; 2017; 54:1209-1222 10.1111/psyp.12874
• Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study Cite
  Cerulla N, Arcusa À, Navarro J, Garolera M, Enero C, Chico G, et al. Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:179-187 10.1007/s10549-017-4240-6
• KU32 prevents 5-fluorouracil induced cognitive impairment Cite
  Sofis MJ, Jarmolowicz DP, Kaplan SV, Gehringer RC, Lemley SM, Garg G, et al. KU32 prevents 5-fluorouracil induced cognitive impairment. Behavioural Brain Research. Elsevier BV; 2017; 329:186-190 10.1016/j.bbr.2017.03.042
• Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study Cite
  Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HSA, Reneman L, et al. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2017; 12:324-334 10.1007/s11682-017-9695-x
• Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type Cite
  Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HSA, Reneman L, et al. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0171724 10.1371/journal.pone.0171724
• Abstract P4-19-03: A meta-analysis of cognitive impairment in breast cancer survivors treated with chemotherapy Cite
  Bernstein L, McCreath G, Rich J. Abstract P4-19-03: A meta-analysis of cognitive impairment in breast cancer survivors treated with chemotherapy. Poster Session Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-p4-19-03
• Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study Cite
  Ramalho M, Fontes F, Ruano L, Pereira S, Lunet N. Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study. The Breast. Elsevier BV; 2017; 32:173-178 10.1016/j.breast.2017.01.018
• Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors Cite
  Huang Z, Zheng Y, Bao P, Cai H, Hong Z, Ding D, et al. Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors. Oncotarget. Impact Journals, LLC; 2016; 8:12364-12373 10.18632/oncotarget.12565
• Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy Cite
  Berndt U, Leplow B, Schoenfeld R, Lantzsch T, Grosse R, Thomssen C. Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy. Breast Care. S. Karger AG; 2016; 11:240-246 10.1159/000446901
• Estrogens - the Saviors of Cognitive Function? Cite
  Pfeiler G. Estrogens - the Saviors of Cognitive Function?. Breast Care. S. Karger AG; 2016; 11:238-239 10.1159/000448636
• Tart cherry supplementation improves working memory, hippocampal inflammation, and autophagy in aged rats Cite
  Thangthaeng N, Poulose SM, Gomes SM, Miller MG, Bielinski DF, Shukitt-Hale B. Tart cherry supplementation improves working memory, hippocampal inflammation, and autophagy in aged rats. AGE. Springer Science and Business Media LLC; 2016; 38:393-404 10.1007/s11357-016-9945-7
• Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer Cite
  Rendeiro C, Sheriff A, Bhattacharya TK, Gogola JV, Baxter JH, Chen H, et al. Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer. Behavioural Brain Research. Elsevier BV; 2016; 315:10-22 10.1016/j.bbr.2016.07.043
• Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) Cite
  Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, et al. Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. Wiley; 2016; 122:3555-3563 10.1002/cncr.30208
• Relationship between self-reported and objectively measured physical activity and subjective memory impairment in breast cancer survivors: role of self-efficacy, fatigue and distress Cite
  Phillips SM, Lloyd GR, Awick EA, McAuley E. Relationship between self-reported and objectively measured physical activity and subjective memory impairment in breast cancer survivors: role of self-efficacy, fatigue and distress. Psycho-Oncology. Wiley; 2016; 26:1390-1399 10.1002/pon.4156
• Is Cancer Protective for Subsequent Alzheimer’s Disease Risk? Evidence From the Utah Population Database Cite
  Hanson HA, Horn KP, Rasmussen KM, Hoffman JM, Smith KR. Is Cancer Protective for Subsequent Alzheimer’s Disease Risk? Evidence From the Utah Population Database. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences. Oxford University Press (OUP); 2016;:gbw040 10.1093/geronb/gbw040
• Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey Cite
  Williams AM, Janelsins MC, van Wijngaarden E. Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey. Supportive Care in Cancer. Springer Science and Business Media LLC; 2015; 24:2155-2162 10.1007/s00520-015-2992-2
• Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy Cite
  Van Dyk K, Petersen L, Ganz PA. Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy. JAMA Oncology. American Medical Association (AMA); 2016; 2:964 10.1001/jamaoncol.2016.0350
• Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors Cite
  Cooke GE, Wetter NC, Banducci SE, Mackenzie MJ, Zuniga KE, Awick EA, et al. Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0149552 10.1371/journal.pone.0149552
• Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis Cite
  Jung MS, Zhang M, Askren MK, Berman MG, Peltier S, Hayes DF, et al. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2016; 11:86-97 10.1007/s11682-016-9507-8
• Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls Cite
  Wang L, Apple AC, Schroeder MP, Ryals AJ, Voss JL, Gitelman D, et al. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls. Cancer. Wiley; 2015; 122:258-268 10.1002/cncr.29737
• Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors Cite
  Kesler SR, Blayney DW. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncology. American Medical Association (AMA); 2016; 2:185 10.1001/jamaoncol.2015.4333
• Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer Cite
  Sato C, Sekiguchi A, Kawai M, Kotozaki Y, Nouchi R, Tada H, et al. Postoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast Cancer. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0140655 10.1371/journal.pone.0140655
• Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression Cite
  Nashed MG, Seidlitz EP, Frey BN, Singh G. Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression. Behavioural Brain Research. Elsevier BV; 2015; 294:25-35 10.1016/j.bbr.2015.07.040
• A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules Cite
  Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. Journal of Experimental Medicine. Rockefeller University Press; 2015; 212:991-999 10.1084/jem.20142290
• Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation Cite
  Kitamura Y, Hattori S, Yoneda S, Watanabe S, Kanemoto E, Sugimoto M, et al. Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behavioural Brain Research. Elsevier BV; 2015; 292:184-193 10.1016/j.bbr.2015.06.007
• Objectively measured physical activity and cognitive functioning in breast cancer survivors Cite
  Marinac CR, Godbole S, Kerr J, Natarajan L, Patterson RE, Hartman SJ. Objectively measured physical activity and cognitive functioning in breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2014; 9:230-238 10.1007/s11764-014-0404-0
• Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer Cite
  Kesler SR, Watson CL, Blayney DW. Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiology of Aging. Elsevier BV; 2015; 36:2429-2442 10.1016/j.neurobiolaging.2015.04.015
• Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study Cite
  Kam J, Brenner C, Handy T, Boyd L, Liu-Ambrose T, Lim H, et al. Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study. Clinical Neurophysiology. Elsevier BV; 2016; 127:369-378 10.1016/j.clinph.2015.03.007
• Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress Cite
  Hermelink K, Voigt V, Kaste J, Neufeld F, Wuerstlein R, Buhner M, et al. Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107:djv099-djv099 10.1093/jnci/djv099
• Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study Cite
  Sun L, Chen H, Liang J, Kao C. Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study. QJM. Oxford University Press (OUP); 2015; 109:103-109 10.1093/qjmed/hcv072
• Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control Cite
  Piccirillo JF, Hardin FM, Nicklaus J, Kallogjeri D, Wilson M, Ma CX, et al. Cognitive Impairment after Chemotherapy Related to Atypical Network Architecture for Executive Control. Oncology. S. Karger AG; 2015; 88:360-368 10.1159/000370117
• Prevalence of Cerebral Small-Vessel Disease in Long-Term Breast Cancer Survivors Exposed to Both Adjuvant Radiotherapy and Chemotherapy Cite
  Koppelmans V, Vernooij MW, Boogerd W, Seynaeve C, Ikram MA, Breteler MM, et al. Prevalence of Cerebral Small-Vessel Disease in Long-Term Breast Cancer Survivors Exposed to Both Adjuvant Radiotherapy and Chemotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:588-593 10.1200/jco.2014.56.8345
• Perceived Cognitive Function in Breast Cancer Survivors: Evaluating Relationships With Objective Cognitive Performance and Other Symptoms Using the Functional Assessment of Cancer Therapy—Cognitive Function Instrument Cite
  Von Ah D, Tallman EF. Perceived Cognitive Function in Breast Cancer Survivors: Evaluating Relationships With Objective Cognitive Performance and Other Symptoms Using the Functional Assessment of Cancer Therapy—Cognitive Function Instrument. Journal of Pain and Symptom Management. Elsevier BV; 2015; 49:697-706 10.1016/j.jpainsymman.2014.08.012
• Decision-making impairments in breast cancer patients treated with tamoxifen Cite
  Chen X, Li J, Chen J, Li D, Ye R, Zhang J, et al. Decision-making impairments in breast cancer patients treated with tamoxifen. Hormones and Behavior. Elsevier BV; 2014; 66:449-456 10.1016/j.yhbeh.2014.07.005
• Long-term cognitive function change among breast cancer survivors Cite
  Zheng Y, Luo J, Bao P, Cai H, Hong Z, Ding D, et al. Long-term cognitive function change among breast cancer survivors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 146:599-609 10.1007/s10549-014-3044-1
• Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type Cite
  Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2014; 9:275-284 10.1007/s11682-014-9305-0
• Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints Cite
  Deprez S, Vandenbulcke M, Peeters R, Emsell L, Smeets A, Christiaens M, et al. Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2031-2038 10.1200/jco.2013.53.6219
• Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity? Cite
  Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A, et al. Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:1909-1918 10.1200/jco.2013.54.2050
• Self-Reported History of Chemotherapy and Cognitive Decline in Adults Aged 60 and Older: The PATH Through Life Project Cite
  Anstey KJ, Sargent-Cox K, Cherbuin N, Sachdev PS. Self-Reported History of Chemotherapy and Cognitive Decline in Adults Aged 60 and Older: The PATH Through Life Project. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. Oxford University Press (OUP); 2013; 70:729-735 10.1093/gerona/glt195
• Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats Cite
  Winocur G, Wojtowicz JM, Huang J, Tannock IF. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats. Psychopharmacology. Springer Science and Business Media LLC; 2013; 231:2311-2320 10.1007/s00213-013-3394-0
• A randomized trial of cognitive rehabilitation in cancer survivors Cite
  Cherrier M, Anderson K, David D, Higano C, Gray H, Church A, et al. A randomized trial of cognitive rehabilitation in cancer survivors. Life Sciences. Elsevier BV; 2013; 93:617-622 10.1016/j.lfs.2013.08.011
• Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: A neuropsychological study Cite
  Chen X, Zhu C, Li J, Qiu L, Zhang L, Yu F, et al. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: A neuropsychological study. Brain Research. Elsevier BV; 2013; 1533:63-72 10.1016/j.brainres.2013.08.015
• Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study Cite
  Dumas JA, Makarewicz J, Schaubhut GJ, Devins R, Albert K, Dittus K, et al. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging and Behavior. Springer Science and Business Media LLC; 2013; 7:524-532 10.1007/s11682-013-9244-1
• Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia Cite
  Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Schagen SB. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Critical Reviews in Oncology/Hematology. Elsevier BV; 2013; 88:87-101 10.1016/j.critrevonc.2013.04.002
• Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors Cite
  Kesler S, Hadi Hosseini S, Heckler C, Janelsins M, Palesh O, Mustian K, et al. Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors. Clinical Breast Cancer. Elsevier BV; 2013; 13:299-306 10.1016/j.clbc.2013.02.004
• Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance Cite
  Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DHS, et al. Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2013; 105:791-801 10.1093/jnci/djt073
• Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment? Cite
  Buwalda B, Schagen SB. Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?. Life Sciences. Elsevier BV; 2013; 93:581-588 10.1016/j.lfs.2012.12.012
• Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage Cite
  Conroy SK, McDonald BC, Smith DJ, Moser LR, West JD, Kamendulis LM, et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 137:493-502 10.1007/s10549-012-2385-x
• Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain Cite
  Nokia MS, Anderson ML, Shors TJ. Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain. European Journal of Neuroscience. Wiley; 2012; 36:3521-3530 10.1111/ejn.12007
• Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer Cite
  Yang M, Kim J, Kim J, Jang S, Kim S, Kim J, et al. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Research Bulletin. Elsevier BV; 2012; 89:50-56 10.1016/j.brainresbull.2012.07.003
• Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors Cite
  Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior, and Immunity. Elsevier BV; 2013; 30:S109-S116 10.1016/j.bbi.2012.05.017
• Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study Cite
  McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity. Elsevier BV; 2013; 30:S117-S125 10.1016/j.bbi.2012.05.007
• Long-term toxic effects of adjuvant chemotherapy in breast cancer Cite
  Azim H, de Azambuja E, Colozza M, Bines J, Piccart M. Long-term toxic effects of adjuvant chemotherapy in breast cancer. Annals of Oncology. Elsevier BV; 2011; 22:1939-1947 10.1093/annonc/mdq683
• Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy Cite
  Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:1080-1086 10.1200/jco.2011.37.0189
• Effects of multiple daily genistein treatments on delayed alternation and a differential reinforcement of low rates of responding task in middle-aged rats Cite
  Neese SL, Bandara SB, Doerge DR, Helferich WG, Korol DL, Schantz SL. Effects of multiple daily genistein treatments on delayed alternation and a differential reinforcement of low rates of responding task in middle-aged rats. Neurotoxicology and Teratology. Elsevier BV; 2012; 34:187-195 10.1016/j.ntt.2011.09.002
• Effects of herbal and dietary supplements on cognition in menopause: A systematic review Cite
  Clement YN, Onakpoya I, Hung SK, Ernst E. Effects of herbal and dietary supplements on cognition in menopause: A systematic review. Maturitas. Elsevier BV; 2011; 68:256-263 10.1016/j.maturitas.2010.12.005
• Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning Cite
  Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, et al. Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2012; 30:274-281 10.1200/jco.2011.36.8571
• Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment Cite
  Hill-Kayser CE, Vachani C, Hampshire MK, Di Lullo GA, Metz JM. Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-Conserving Treatment. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 83:839-844 10.1016/j.ijrobp.2011.08.013
• Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval Cite
  Bergouignan L, Lefranc JP, Chupin M, Morel N, Spano JP, Fossati P. Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval. PLoS ONE. Public Library of Science (PLoS); 2011; 6:e25349 10.1371/journal.pone.0025349
• Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging Cite
  de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping. Wiley; 2011; 33:2971-2983 10.1002/hbm.21422
• One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer Cite
  Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, et al. One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2011; 81:795-803 10.1016/j.ijrobp.2010.06.037
• Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial Cite
  Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1294-1300 10.1200/jco.2008.21.3553